CAM
ESPR

ClariVest Asset Management’s Esperion Therapeutics ESPR Stock Holding History

ClariVest Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-65,304
Closed -$3.35M – 782
2020
Q2 		$3.35M Buy
65,304
+2,382
+4% +$99.7K 0.09% 165
2020
Q1 		$1.98M Sell
62,922
-3,313
-5% -$175K 0.06% 199
2019
Q4 		$3.95M Sell
66,235
-21,742
-25% -$978K 0.09% 165
2019
Q3 		$3.23M Sell
87,977
-1,000
-1% -$39.6K 0.07% 202
2019
Q2 		$4.14M Buy
+88,977
New +$4.18M 0.09% 181

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return